Search research articles
Contact Us
Filters
Showing results (81-90 of 338) with videos related to
Page
of 34
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 23, 2005
Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy
Melissa P Upton, Robert A Parker, Amanda Youmans, et al.
Pediatric Dermatology
|
August 14, 2015
Correlates of Sun Safety Practices in a Racially and Ethnically Diverse Sample of Adolescents: Implications for Skin Cancer Prevention Interventions
Darren Mays, Kirsten B Hawkins, Vida L Tyc, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 24, 2021
Immunotherapy Utilization Among Patients With Metastatic NSCLC: Impact of Comorbidities
Dongyu Zhang, Tina D Tailor, Chul Kim, et al.
JCO Oncology Practice
|
December 1, 2023
Systemic Therapy for Melanoma: ASCO Guideline Update Q and A
Vernon K Sondak, Michael B Atkins, Hans Messersmith, et al.
Urologic Oncology
|
November 13, 2012
Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: analysis from the treatment approaches in renal cancer global evaluation trial (TARGET)
Toni K Choueiri, Suchun Cheng, Angela Q Qu, et al.
Clinical Genitourinary Cancer
|
February 14, 2009
Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma
Kathryn A Bylow, Michael B Atkins, Edwin M Posadas, et al.
Journal of Medical Economics
|
October 13, 2012
Ipilimumab in 2nd line treatment of patients with advanced melanoma: a cost-effectiveness analysis
Victor Barzey, Michael B Atkins, Louis P Garrison, et al.
Seminars in Oncology
|
December 8, 2009
Clinical trial experience with temsirolimus in patients with advanced renal cell carcinoma
Gary R Hudes, Anna Berkenblit, Jay Feingold, et al.
The American Journal of Dermatopathology
|
August 20, 2016
Discordance Between Cobas BRAF V600 Testing and VE1 Immunohistochemistry in a Melanoma Patient With Bone Marrow Metastases
Suthee Rapisuwon, Klaus J Busam, Kellie Parks, et al.
Therapeutic Advances in Medical Oncology
|
June 18, 2019
Management of metastatic cutaneous melanoma: updates in clinical practice
Gustavo Schvartsman, Patricia Taranto, Isabella C Glitza, et al.
Page
of 34
Search research articles
Search
Showing results (81-90 of 338) with videos related to
Sort By:
Page
of 34
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 23, 2005
Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy
Melissa P Upton, Robert A Parker, Amanda Youmans, et al.
Pediatric Dermatology
|
August 14, 2015
Correlates of Sun Safety Practices in a Racially and Ethnically Diverse Sample of Adolescents: Implications for Skin Cancer Prevention Interventions
Darren Mays, Kirsten B Hawkins, Vida L Tyc, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 24, 2021
Immunotherapy Utilization Among Patients With Metastatic NSCLC: Impact of Comorbidities
Dongyu Zhang, Tina D Tailor, Chul Kim, et al.
JCO Oncology Practice
|
December 1, 2023
Systemic Therapy for Melanoma: ASCO Guideline Update Q and A
Vernon K Sondak, Michael B Atkins, Hans Messersmith, et al.
Urologic Oncology
|
November 13, 2012
Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: analysis from the treatment approaches in renal cancer global evaluation trial (TARGET)
Toni K Choueiri, Suchun Cheng, Angela Q Qu, et al.
Clinical Genitourinary Cancer
|
February 14, 2009
Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma
Kathryn A Bylow, Michael B Atkins, Edwin M Posadas, et al.
Journal of Medical Economics
|
October 13, 2012
Ipilimumab in 2nd line treatment of patients with advanced melanoma: a cost-effectiveness analysis
Victor Barzey, Michael B Atkins, Louis P Garrison, et al.
Seminars in Oncology
|
December 8, 2009
Clinical trial experience with temsirolimus in patients with advanced renal cell carcinoma
Gary R Hudes, Anna Berkenblit, Jay Feingold, et al.
The American Journal of Dermatopathology
|
August 20, 2016
Discordance Between Cobas BRAF V600 Testing and VE1 Immunohistochemistry in a Melanoma Patient With Bone Marrow Metastases
Suthee Rapisuwon, Klaus J Busam, Kellie Parks, et al.
Therapeutic Advances in Medical Oncology
|
June 18, 2019
Management of metastatic cutaneous melanoma: updates in clinical practice
Gustavo Schvartsman, Patricia Taranto, Isabella C Glitza, et al.
Page
of 34